The Autosomal Dominant Polycystic Kidney Disease Treatment Market is experiencing steady growth as healthcare systems strengthen their focus on managing chronic and genetic kidney diseases. Enhanced diagnostic capabilities and expanding treatment options are supporting better disease management. These developments are contributing to the market's positive outlook. The global Autosomal...